1. sEVsRVG selectively delivers antiviral siRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV-induced microcephaly in mouse model
   Rui Zhang et al, 2022, Molecular Therapy CrossRef
2. Co-expression Network Analysis Reveals Novel Genes Underlying Alzheimer’s Disease Pathogenesis
   Rui-ting Hu et al, 2020, Frontiers in Aging Neuroscience CrossRef
3. Exogenous Aβ1-42 monomers improve synaptic and cognitive function in Alzheimer's disease model mice
   Yanhong Duan et al, 2022, Neuropharmacology CrossRef
4. Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds
   Weimin Qiu et al, 2023, Medicinal Research Reviews CrossRef
5. Aconiti lateralis Radix Praeparata inhibits Alzheimer’s disease by regulating the complex regulation network with the core of GRIN1 and MAPK1
   Yutao Wang et al, 2021, Pharmaceutical Biology CrossRef
6. Palmatine improves cognitive dysfunction in Alzheimer's disease model rats through autophagy pathway and regulation of gut microbiota
   Lu Han et al, 2024, Brain Research CrossRef
7. Alpha7 nicotinic acetylcholine receptor agonist PHA-543613 improves memory deficits in presenilin 1 and presenilin 2 conditional double knockout mice
   Junyan Lv et al, 2023, Experimental Neurology CrossRef
8. A Novel Peptide Driving Neurodegeneration Appears Exclusively Linked to the α7 Nicotinic Acetylcholine Receptor
   Sanskar Ranglani et al, 2024, Molecular Neurobiology CrossRef
9. Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia
   Boris Decourt et al, 2022, Journal of Experimental Pharmacology CrossRef
10. Molecular mechanisms of Alzheimer's disease: From therapeutic targets to promising drugs
    Elif Alan et al, 2023, Fundamental & Clinical Pharmacology CrossRef
11. Unraveling the molecular interactions between α7 nicotinic receptor and a RIC3 variant associated with backward speech
    Aditi Pradhan et al, 2024, Cellular and Molecular Life Sciences CrossRef
12. Modes of Acetylcholine Signaling in the Prefrontal Cortex: Implications for Cholinergic Dysfunction and Disorders
    Matthew Fecik et al, 2023, Acetylcholine - Recent Advances and New Perspectives CrossRef
13. Unbalanced Regulation of α7 nAChRs by Ly6h and NACHO Contributes to Neurotoxicity in Alzheimer's Disease
    Meilin Wu et al, 2021, The Journal of Neuroscience CrossRef
14. Multifunctional Metal–Organic Framework as a Versatile Nanoplatform for Aβ Oligomer Imaging and Chemo-Photothermal Treatment in Living Cells
    Xueyan Yan et al, 2021, Analytical Chemistry CrossRef
15. Recent advances in nanotechnology for combating Alzheimer's disease
    Chuan Hu et al, 2023, Materials Chemistry Frontiers CrossRef
16. Nicotinic acetylcholine receptor subtype expression, function, and pharmacology: Therapeutic potential of α-conotoxins
    Han-Shen Tae et al, 2023, Pharmacological Research CrossRef
17. Post‐transcriptional regulation of α7 nAChR expression by miR‐98‐5p modulates cognition and neuroinflammation in an animal model of Alzheimer's disease
    Chenghuan Song et al, 2021, The FASEB Journal CrossRef
18. Brain‐Penetration and Neuron‐Targeting DNA Nanoflowers Co‐Delivering miR‐124 and Rutin for Synergistic Therapy of Alzheimer's Disease
    Qin Ouyang et al, 2022, Small CrossRef
19. Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by Aβ1–42 through Nrf2/HO-1 and NF-κB signaling pathway in mice
    ShiYu Jin et al, 2021, International Immunopharmacology CrossRef
20. Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
    Divya Yadav et al, 2022, Neurochemistry International CrossRef
21. Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer’s Disease
    Kazuyuki Takata et al, 2022, Molecules CrossRef